MSH|^~\&|SendAppName^2.16.840.1.114222.TBD^ISO|Sending-Facility^2.16.840.1.114222.TBD^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20140630120030.1234-0500||ORU^R01^ORU_R01|MESSAGE CONTROL ID|D|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~Malaria_MMG_V1.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||Malaria_Sample02^^^SendAppName&2.16.840.1.114222.nnnn&ISO||~^^^^^^S||19320515|M||ASKU^asked but unknown^NULLFL|^^^06^90001^^^^06037|||||||||||UNK^unknown^NULLFL||||||||||||||||OBR|1||Malaria_Sample02^SendAppName^2.16.840.1.114222.TBD^ISO|68991-9^Epidemiologic Information^LN|||20160526100100|||||||||||||||20160526100100|||F||||||10130^Malaria^NNDOBX|1|CWE|78746-5^Country of Birth^LN||FRA^FRANCE^ISO3166_1||||||FOBX|2|CWE|77983-5^Country of Usual Residence^LN||FRA^FRANCE^ISO3166_1||||||FOBX|3|TS|11368-8^Date of Illness Onset^LN||2016||||||FOBX|4|SN|78033-8^Duration of Hospital Stay in Days^LN||^14||||||FOBX|5|CWE|77978-5^Subject Died^LN||UNK^Unknown^NULLFL||||||FOBX|6|ST|77993-4^State Case Identifier^LN||713982||||||FOBX|7|ST|77997-5^Legacy Case Identifier^LN||125498706842016||||||FOBX|8|SN|77998-3^Age at Case Investigation^LN||^84|a^year [time]^UCUM|||||FOBX|9|CWE|77982-7^Case Disease Imported Code^LN||C1512888^International^UML||||||FOBX|10|TS|77976-9^Illness End Date^LN||20160704||||||FOBX|11|CWE|INV153^Imported Country^PHINQUESTION||DOM^DOMINICAN REPUBLIC^ISO3166_1||||||FOBX|12|SN|77977-7^Illness Duration^LN||^1|a^year [time]^UCUM|||||FOBX|13|CWE|77996-7^Pregnancy Status^LN||N^No^HL70136||||||FOBX|14|TS|77975-1^Diagnosis Date^LN||20160525||||||FOBX|15|CWE|77974-4^Hospitalized^LN||Y^Yes^HL70136||||||FOBX|16|CWE|77984-3^Country of Exposure^LN|1|DOM^DOMINICAN REPUBLIC^ISO3166_1||||||FOBX|17|ST|77986-8^City of Exposure^LN|1|Punta Cana||||||FOBX|18|ST|52831-5^Reporting Source ZIP Code^LN||90001||||||FOBX|19|ST|74549-7^Person Reporting to CDC - Name^LN||Albert Einstein||||||FOBX|20|ST|74548-9^Person Reporting to CDC - Phone Number^LN||323-555-5309||||||FOBX|21|ST|74547-1^Person Reporting to CDC - Email^LN||emc2@reallysmart.gov||||||FOBX|22|DT|77979-3^Case Investigation Start Date^LN||20160526||||||FOBX|23|DT|77995-9^Date Reported^LN||20160526||||||FOBX|24|TS|77972-8^Earliest Date Reported to County^LN||20160526||||||FOBX|25|CWE|77989-2^Transmission Mode^LN||418427004^Vector-borne transmission^SCT||||||FOBX|26|TS|77973-6^Earliest Date Reported to State^LN||20160526||||||FOBX|27|SN|77991-8^MMWR Week^LN||^23||||||FOBX|28|DT|77992-6^MMWR Year^LN||2016||||||FOBX|29|DT|77970-2^Date First Reported to PHD^LN||20160527||||||FOBX|30|CWE|77966-0^Reporting State^LN||06^California^FIPS5_2||||||FOBX|31|CWE|77967-8^Reporting County^LN||06037^Los Angeles, CA^FIPS6_4||||||FOBX|32|CWE|77968-6^National Reporting Jurisdiction^LN||06^CA^FIPS5_2||||||FOBX|33|TX|77999-1^Comment^LN||Subject is a resident of France, who traveled to the US for tourism, following travel to malaria endemic countries.||||||FOBX|34|CWE|77990-0^Case Class Status Code^LN||410605003^Confirmed present^SCT||||||FOBX|35|CWE|77965-2^Immediate National Notifiable Condition^LN||N^No^HL70136||||||FOBX|36|ST|77969-4^Jurisdiction Code^LN||S01||||||FOBX|37|CWE|48766-0^Reporting Source Type Code^LN||PHC247^Laboratory^CDCPHINVS||||||FOBX|38|ST|45394-4^Subject's Last Name^LN||Gally||||||FOBX|39|ST|45392-8^Subject's First Name^LN||Armond||||||FOBX|40|SN|3137-7^Height^LN||^71|[in_us]^inch [length]^UCUM|||||FOBX|41|SN|3141-9^Weight^LN||^60|kg^KiloGram [SI Mass Units]^UCUM|||||FOBX|42|ST|52526-1^Physician Name^LN|2|Oz, Mehmet||||||FOBX|43|ST|68340-9^Physician Phone^LN|2|456-123-7890||||||FOBX|44|ST|52526-1^Physician Name^LN|3|Gupta, Sanjay||||||FOBX|45|ST|68340-9^Physician Phone^LN|3|888-999-1010||||||FOBX|46|DT|52455-3^Admission Date^LN|4|20160521||||||FOBX|47|DT|52525-3^Discharge Date^LN|4|20160604||||||FOBX|48|CWE|32485007^Admitted as Inpatient^SCT|4|Y^Yes^HL70136||||||FOBX|49|CWE|161413004^History of Previous Illness^SCT||Y^Yes^HL70136||||||FOBX|50|DT|82758-4^Date of Previous Illness^LN|5|201608||||||FOBX|51|CWE|67187-5^Type of Complications^LN||53622003^Cerebral malaria^SCT~42399005^Renal failure^SCT~PHC911^Severe anemia (Hb<7)^CDCPHINVS~67782005^ARDS^SCT||||||FOBX|52|CWE|182929008^Chemoprophylaxis^SCT||Y^Yes^HL70136||||||FOBX|53|CWE|INV931^Chemoprophylaxis Medication(s)^PHINQUESTION||3640^Doxycycline^RXNORM||||||FOBX|54|CWE|INV309^Chemoprophylaxis Taken as Prescribed^PHINQUESTION||N^No^HL70136||||||FOBX|55|CWE|INV932^Reason Doses Missed^PHINQUESTION||PHC914^Was advised by others to stop^CDCPHINVS~401207004^Had a side effect^SCT||||||FOBX|56|ST|INV921^Side Effect that Caused Missed Doses^PHINQUESTION||Sun sensitivity||||||FOBX|57|CWE|55753-8^Treatment Information^LN|6|2393^Chloroquine^RXNORM||||||FOBX|58|DT|86948-7^Date Treatment or Therapy Started^LN|6|20160522||||||FOBX|59|DT|63939-3^Date Treatment or Therapy Stopped^LN|6|20160604||||||FOBX|60|SN|67453-1^Treatment Duration^LN|6|^13|d^day^UCUM|||||FOBX|61|CWE|82312-0^Received Blood Transfusion/Organ Transplant^LN||Y^Yes^HL70136||||||FOBX|62|DT|80989-7^Blood Transfusion/Organ Transplant Date^LN||20150810||||||FOBX|63|CWE|TRAVEL10^Subject Traveled or Lived Outside US^PHINQUESTION||Y^Yes^HL70136||||||FOBX|64|CWE|TRAVEL15^Subject's Country of Residence Prior to Most Recent Travel^PHINQUESTION||FRA^FRANCE^ISO3166_1||||||FOBX|65|CWE|82764-2^International Destination(s) of Recent Travel^LN|7|DOM^Dominican Republic^ISO3166_1||||||FOBX|66|DT|55209-1^Date of Return to the US from Travel^LN|7|20160514||||||FOBX|67|SN|82310-4^Duration of Stay^LN|7|^7|d^day [time]^UCUM|||||FOBX|68|CWE|66415-1^Reason(s) for Travel^LN|7|PHC386^Business^CDCPHINVS~C0683587^Tourism^UMLS||||||FOBX|69|CWE|82764-2^International Destination(s) of Recent Travel^LN|8|IND^India^ISO3166_1||||||FOBX|70|DT|55209-1^Date of Return to the US from Travel^LN|8|20160507||||||FOBX|71|SN|82310-4^Duration of Stay^LN|8|^2|d^day [time]^UCUM|||||FOBX|72|CWE|66415-1^Reason(s) for Travel^LN|8|PHC386^Business^CDCPHINVS||||||FOBX|73|CWE|82314-6^Specimen Sent to CDC^LN||Y^Yes^HL70136||||||FOBX|74|CWE|66746-9^Specimen Type(s) Sent to CDC^LN|9|258580003^Whole Blood^SCT||||||FOBX|75|ST|INV965^CSID^PHINQUESTION|9|3000234568||||||FOBX|76|CWE|INV290^Test Type^PHINQUESTION|10|10710-2^Blood Smear^LN||||||FOBX|77|CWE|INV291^Test Result^PHINQUESTION|10|10828004^Positive^SCT||||||FOBX|78|TS|68963-8^Specimen Collection Date/Time^LN|10|20160525||||||FOBX|79|TS|82773-3^Date/Time of Lab Result^LN|10|20160526||||||FOBX|80|CWE|LAB278^Organism Name^PHINQUESTION|10|56395006^Malariae^SCT||||||FOBX|81|ST|68994-3^Performing Laboratory Name^LN|10|CA PHL||||||FOBX|82|ST|65651-2^Laboratory Phone Number^LN|10|232-555-5309||||||FOBX|83|SN|53556-7^Parasitemia Level Percentage^LN|10|^2.5||||||FOBX|84|CWE|INV290^Test Type^PHINQUESTION|11|10710-2^Blood Smear^LN||||||FOBX|85|CWE|INV291^Test Result^PHINQUESTION|11|10828004^Positive^SCT||||||FOBX|86|TS|68963-8^Specimen Collection Date/Time^LN|11|20160527||||||FOBX|87|TS|82773-3^Date/Time of Lab Result^LN|11|20160528||||||FOBX|88|CWE|LAB278^Organism Name^PHINQUESTION|11|56395006^Malariae^SCT||||||FOBX|89|ST|68994-3^Performing Laboratory Name^LN|11|CA Public Health Lab||||||FOBX|90|ST|65651-2^Laboratory Phone Number^LN|11|232-555-5309||||||FOBX|91|SN|53556-7^Parasitemia Level Percentage^LN|11|^1||||||FOBX|92|CWE|INV917^Treatment Taken as Prescribed^PHINQUESTION||Y^Yes^HL70136||||||FOBX|93|CWE|313185002^Symptoms Resolved After Treatment^SCT||Y^Yes^HL70136||||||FOBX|94|CWE|161917009^Recurrence of Symptoms After Treatment^SCT||N^No^HL70136||||||FOBX|95|CWE|391103005^Adverse Events After Treatment^SCT||Y^Yes^HL70136||||||FOBX|96|TX|42563-7^Adverse Event Description^LN|13|Vomiting||||||FOBX|97|CWE|INV918^Adverse Event Related to Treatment^PHINQUESTION|13|Y^Yes^HL70136||||||FOBX|98|SN|82311-2^Adverse Event Time to Onset^LN|13|^2|h^hour [time]^UCUM|||||FOBX|99|CWE|64750-3^Adverse Event Severity^LN|13|C1518404^Non serious^UMLS||||||FOBX|100|TX|42563-7^Adverse Event Description^LN|14|headache with blurred vision||||||FOBX|101|CWE|INV918^Adverse Event Related to Treatment^PHINQUESTION|14|Y^Yes^HL70136||||||FOBX|102|SN|82311-2^Adverse Event Time to Onset^LN|14|^2|h^hour [time]^UCUM|||||FOBX|103|CWE|64750-3^Adverse Event Severity^LN|14|PHC2178^Medically important^PHINVS||||||FOBX|104|ST|29303-5^Medication Administered^LN|15|Krintafel, amoxicillin||||||FOBX|105|CWE|INV1284^Medication Administered Relative to Treatment^PHINQUESTION|15|PHC2146^During 4 weeks after treatment^CDCPHINVS||||||FOBX|106|DT|91381-4^Medication Start Date^LN|15|20160618||||||FOBX|107|DT|91382-2^Medication Stop Date^LN|15|20160525||||||FOBX|108|SN|91383-0^Medication Duration^LN|15|^7||||||F